Role of Toll like receptor signaling pathway in ischemic coronary artery disease

Frontiers in Bioscience

Volumn 13, Issue 17, 2008, Pages 6708-6715

  Satoh, Mamoru ^a   Ishikawa, Yuh ^a   Minami, Yoshitaka ^a   Takahashi, Yuji ^a   Nakamura, Motoyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Arterial remodeling; Heat shock protein 70; Inflammatory cytokine; Ventricular remodeling; Vulnerable coronary plaque

Indexed keywords

MAMMALIA;

TOLL LIKE RECEPTOR;

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HUMANS; INFLAMMATION; MYOCARDIAL ISCHEMIA; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 52049124515     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Libby P: Inflammation in atherosclerosis. Nature, 420, 868-874 (2002) (Pubitemid 36019640)
2. Ross R: Atherosclerosis - an inflammatory disease. N. Engl. J. Med., 340, 115-126 (1999) (Pubitemid 29054847)
3. Kolodgie F.D, R. Virmani, A.P. Burke, A. Farb, D. K. Weber, R. Kutys, A.V. Finn, H.K. Gold: Pathologic assessment of the vulnerable human coronary plaque. Heart, 90, 1385-1391 (2004) (Pubitemid 39626306)
4. Gutstein DE, V. Fuster: Pathophysiology and clinical significance of atherosclerotic plaque rupture. Cardiovasc. Res., 41, 323-333 (1999) (Pubitemid 29087329)
5. Mauriello A, G. Sangiorgi, S. Fratoni, G. Palmieri, E. Bonanno, L. Anemona, R.S. Schwartz, L.G. Spagnoli: Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. J. Am. Coll. Cardiol., 45,1585-1593 (2005) (Pubitemid 40704490)
6. Cooper H.A, D.V. Exner, M.A. Waclawiw, M.J. Domanski: White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction (SOLVD)). Am. J. Cardiol., 84, 252-257 (1999) (Pubitemid 29365118)
7. Maekawa Y, T. Anzai, T. Yoshikawa, Y. Asakura, T. Takahashi, S. Ishikawa, H. Mitamura, S. Ogawa. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J. Am. Coll. Cardiol., 39, 241-246 (2002) (Pubitemid 34084628)
8. Furman M.I, J.M. Gore, F. A. Anderson, A. Budaj, S.G. Goodman, A. Avezum, J. López-Sendón, W. Klein, D. Mukherjee, K. A. Eagle, O.H. Dabbous, R.J. Goldberg; GRACE Investigators: Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am. Heart J., 147, 42-48 (2004) (Pubitemid 38037395)
9. Meisel S.R, H. Pauzner, M. Shechter, Z. Zeidan, D. David: Peripheral monocytosis following acute myocardial infarction: incidence and its possible role as a bedside marker of the extent of cardiac injury. Cardiology, 90, 52-57 (1998) (Pubitemid 28369602)
10. Satoh M, Y. Shimoda, C. Maesawa, T. Akatsu, Y. Ishikawa, Y. Minami, K. Hiramori, M. Nakamura: Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. Int. J. Cardiol., 109, 226-234 (2006)
11. Tashiro H, H. Shimokawa, K. Yamamoto, M. Nagano, M. Momohara, K. Muramatu, A. Takeshita: Monocyterelated cytokines in acute myocardial infarction. Am. Heart J., 130, 446-452 (1995)
12. Marx N, F.J. Neumann, I. Ott, M. Gawaz, W. Koch, T. Pinkau, A. Schömig: Induction of cytokine expression in leukocytes in acute myocardial infarction. J. Am. Coll. Cardiol., 30,165-170 (1997) (Pubitemid 27357142)
13. Medzhitov R: Toll-like receptors and innate immunity. Nat. Rev. Immunol., 1, 135-145 (2001) (Pubitemid 33741967)
14. Takeda K, T. Kaisho, S. Akira: Toll-like receptors. Annu. Rev. Immunol., 21, 335-376 (2003) (Pubitemid 37174535)
15. Akira S, K. Takeda, T. Kaisho: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol., 2,675-680 (2001) (Pubitemid 32747155)
16. Medzhitov R, P. Preston-Hurlburt, C.A. Janeway Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 388, 394-397 (1997) (Pubitemid 27334820)
17. Modlin R.L, H.D. Brightbill, P. Godowski: The Toll of innate immunity on microbial pathogens. N. Engl. J. Med., 340, 1834-1835 (1999) (Pubitemid 29266411)
18. Hashimoto C, K.L. Hudson, K.V. Anderson: The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell, 52, 269-279 (1988)
19. Rock FL, G. Hardiman, J.C. Timans, R.A. Kastelein, J.F. Bazan: A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U.S.A., 95, 588-593 (1998) (Pubitemid 28083787)
20. Gay N.J, F.J. Keith: Drosophila Toll and IL-1 receptor. Nature, 351, 355-356 (1991)
21. Muzio M, J. Ni, P. Feng, V.M. Dixit: IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science, 278, 1612-1615 (1997) (Pubitemid 27516277)
22. Cao Z, W.J. Henzel, X. Gao: IRAK: a kinase associated with the interleukin-1 receptor. Science, 271, 1128-1131 (1996) (Pubitemid 26075229)
23. Woronicz J.D, X. Gao, Z. Cao, M. Rothe, D.V. Goeddel: IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science, 278, 866-869 (1997) (Pubitemid 27467924)
24. Yamamoto Y, R.B. Gaynor: Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest., 107, 135-142 (2001) (Pubitemid 32096826)
25. Lien E, T.J. Sellati, A. Yoshimura, T.H. Flo, G. Rawadi, R.W. Finberg, J.D. Carroll, T. Espevik, R.R. Ingalls, J.D. Radolf, D.T. Golenbock: Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem., 274, 33419-33425 (1999) (Pubitemid 129511647)
26. Qureshi S.T, L. Lariviere, G. Leveque, S. Clermont, K.J. Moore, P. Gros, D. Malo: Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med., 189, 615-625 (1999) (Pubitemid 29193362)
27. Andersen-Nissen E, K.D. Smith, K.L. Strobe, S.L. Barrett, B.T. Cookson, S.M. Logan, A. Aderem: Evasion of Toll-like receptor 5 by flagellated bacteria. Proc. Natl. Acad. Sci. U.S.A., 102, 9247-9252 (2005) (Pubitemid 40923549)
28. Hemmi H, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, S. Akira: A Toll-like receptor recognizes bacterial DNA. Nature, 408, 740-745 (2000) (Pubitemid 32015992)
29. Shinohara M, K. Hirata, T. Yamashita, T. Takaya, N. Sasaki, R. Shiraki, T. Ueyama, N. Emoto, N. Inoue, M. Yokoyama, S. Kawashima: Local overexpression of tolllike receptors at the vessel wall induces atherosclerotic lesion formation: synergism of TLR2 and TLR4. Arterioscler. Thromb. Vasc. Biol., 27, 2384-2391 (2007) (Pubitemid 350203954)
30. Frantz S, R.A. Kelly, T. Bourcier: Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J. Biol. Chem., 276, 5197-5203 (2001)
31. Boekholdt S.M, W.R. Agema, R.J. Peters, A.H. Zwinderman, E.E. van der Wall, R.H. Reitsma, J.J. Kastelein, J.W. Jukema REgression Growth Evaluation Statin Study Group: Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation, 107, 2416-2421 (2003) (Pubitemid 36605222)
32. Kiechl S, E. Lorenz, M. Reindl, C.J. Wiedermann, F. Oberhollenzer, E. Bonora, J. Willeit, D.A. Schwartz: Tolllike receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med., 347, 185-192 (2002)
33. Xu X.H, P.K. Shah, E. Faure, O. Equils, L. Thomas, M.C. Fishbein, D. Luthringer, X.P. Xu, T.B. Rajavashisth, J. Yano, S. Kaul, M. Arditi: Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation, 104, 3103-3108 (2001) (Pubitemid 34014065)
34. Li H &B. Sun: Toll-like receptor 4 in atherosclerosis. J. Cell. Mol. Med., 11, 88-95 (2007) (Pubitemid 46439627)
35. Faure E, O. Equils, P.A. Sieling, L. Thomas, F.X. Zhang, C.J. Kirschning, N. Polentarutti, M. Muzio, M. Arditi: Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem., 275, 11058-11063 (2000) (Pubitemid 30212746)
36. Fan J, R.S. Frey, A.B. Malik: TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J. Clin. Invest., 112, 1234-1243 (2003) (Pubitemid 38056300)
37. Michelsen K.S, M.H. Wong, P.K. Shah, W. Zhang, J. Yano, T.M. Doherty, S. Akira, T.B. Rajavashisth, M. Arditi: Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. U.S.A., 101, 10679-10684 (2004) (Pubitemid 38955802)
38. Björkbacka H, V.V. Kunjathoor, K.J. Moore, S. Koehn, C.M. Ordija, M.A. Lee, T. Means, K. Halmen, A.D. Luster, D.T. Golenbock, M.W. Freeman: Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med., 10, 416-421 (2004) (Pubitemid 38508522)
39. Gough P.J, I.G. Gomez, P.T. Wille, E.W. Raines: Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest, 116, 59-69 (2006) (Pubitemid 43121791)
40. Okamura Y, M. Watari, E.S. Jerud, D.W. Young, S.T. Ishizaka, J. Rose, J.C. Chow, J.F. Strauss 3rd: The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem., 276, 10229-10233 (2001)
41. Ma Y, H. Liu, H. Tu-Rapp, H.J. Thiesen, S.M. Ibrahim, S.M. Cole, R.M. Pope: Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation. Nat. Immunol., 5, 380-387 (2004) (Pubitemid 38500086)
42. Mullick AE, P.S. Tobias, L.K. Curtiss: Modulation of atherosclerosis in mice by Toll-like receptor 2. J. Clin. Invest., 115, 3149-156 (2005) (Pubitemid 41567579)
43. Schoneveld A.H, M.M. Oude Nijhuis, B. van Middelaar, J.D. Laman, D.P. de Kleijn, G. Pasterkamp: Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. Cardiovasc. Res., 66, 162-169 (2005) (Pubitemid 40357879)
44. Barton GM &R. Medzhitov: Toll-like receptor signaling pathways. Science, 300, 1524-1525 (2003) (Pubitemid 36682871)
45. Methe H, J.O. Kim, S. Kofler, M. Weis, M. Nabauer, J. Koglin: Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome. Circulation, 111, 2654-2661 (2005) (Pubitemid 40740866)
46. Versteeg D, I. Hoefer, A. Schoneveld, D. de Kleijn, E. Busser, C. Strijder, M. Emons, P. Stella, P. Doevendans, G. Pasterkamp: Monocyte toll-like Receptor 2 and 4 responses and expression following percutaneous coronary intervention: Association with lesion stenosis and fractional flow reserve. Heart, Epub (2007)
47. Suliman H.B, K.E. Welty-Wolf, M.S. Carraway, D.A. Schwartz, J.W. Hollingsworth, C.A. Piantadosi: Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli. FASEB J., 19, 1531-1533 (2005) (Pubitemid 41279021)
48. Lee J.Y, K.H. Sohn, S.H. Rhee, D.Hwang: Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem., 276, 16683-16689 (2001)
49. Vabulas R.M, P. Ahmad-Nejad, S. Ghose, C.J. Kirschning, R.D. Issels, H. Wagner: HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem., 277, 15107-15112 (2002) (Pubitemid 34952589)
50. Asea A, S.K. Kraeft, E.A. Kurt-Jones, M.A. Stevenson, L.B. Chen, R.W. Finberg, G.C. Koo, S.K. Calderwood: HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med., 6:435-442 (2000) (Pubitemid 30208161)
51. Vabulas RM, P. Ahmad-Nejad, S. Ghose, C.J. Kirschning, R.D. Issels, H.Wagner: HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem., 277, 15107-15112 (2002) (Pubitemid 34952589)
52. Dybdahl B, S.A. Slørdahl, A. Waage, P. Kierulf, T. Espevik, A. Sundan: Myocardial ischemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart, 91, 299-304 (2005) (Pubitemid 40299205)
53. Satoh M, Y. Shimoda, T. Akatsu, Y. Ishikawa, Y. Minami, M. Nakamura: Elevated circulating levels of heat shock protein 70 are related to systemic inflammatory reaction through monocyte Toll signal in patients with heart failure after acute myocardial infarction. Eur. J. Heart Fail., 8, 810-815 (2006) (Pubitemid 44779418)
54. Saikku P, M. Leinonen, K. Mattila, M.R. Ekman, M.S. Nieminen, P.H. Mäkelä, J.K. Huttunen, V. Valtonen: Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet, 2, 983-986 (1988)
55. Kalayoglu M.V, B. Hoerneman, D. LaVerda, S.G. Morrison, R.P. Morrison, G.I. Byrne: Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J. Infect. Dis., 180, 780-790 (1999) (Pubitemid 29411365)
56. Triantafilou M, G.F. Gamper, P.M. Lepper, M.A. Mouratis, C. Schumann, E. Harokopakis, R.E. Schifferle, G. Hajishengallis, K. Triantafilou: Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells. Cell. Microbiol., 9, 2030-2039 (2007) (Pubitemid 47087093)
57. Fan J, Y. Li, Y. Vodovotz, T.R. Billiar, M.A. Wilson: Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation. Am J Physiol Lung Cell. Mol. Physiol., 290, L738-L746 (2006) (Pubitemid 43725079)
58. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation, 108, 2317-2322 (2003) (Pubitemid 37413536)
59. Ueland T, T. Espevik, J. Kjekshus, L. Gullestad, T. Omland, I.B. Squire, S.S. Frøland, T.E. Mollnes, K. Dickstein, P. Aukrust: Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction. J. Card. Fail., 12, 659-63 (2006) (Pubitemid 44540257)
60. Kubota T, M. Miyagishima, C.S. Frye, S.M. Alber, G.S. Bounoutas, T. Kadokami, S.C. Watkins, C.F. McTiernan, A.M. Feldman: Overexpression of tumor necrosis factor-? activates both anti- and pro-apoptotic pathways in the myocardium. J. Mol. Cell. Cardiol. 33, 1331-44 (2001) (Pubitemid 32613425)
61. Hirota H, K. Yoshida, T. Kishimoto, T. Taga: Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc. Natl. Acad. Sci. U.S.A., 92, 4862-4866 (1995)
62. Shah PK: Mechanisms of plaque vulnerability and rupture. J. Am. Coll. Cardiol. 41, 15S-22S (2003) (Pubitemid 36223342)
63. Pasterkamp G, D.P. de Kleijn, C. Borst: Arterial remodeling in atherosclerosis, restenosis and after alteration of blood flow: potential mechanisms and clinical implications. Cardiovasc. Res. 45, 843-852 (2000) (Pubitemid 30089645)
64. Hollestelle S.C, M.R. De Vries, J.K. Van Keulen, A.H. Schoneveld, A. Vink, C.F. Strijder, B.J. Van Middelaar, G. Pasterkamp, P.H. Quax, D.P. De Kleijn: Toll-like receptor 4 is involved in outward arterial remodeling. Circulation, 109, 393-398 (2004) (Pubitemid 38139309)
65. Shimamoto A, A.J. Chong, M. Yada, S. Shomura, H. Takayama, A.J. Fleisig, M.L. Agnew, C.R. Hampton, C.L. Rothnie, D.J. Spring, T.H. Pohlman, H. Shimpo, E.D. Verrier: Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation, 114 (Suppl. 1), I270-I274, (2006) (Pubitemid 44297162)
66. Nakamura M, Y. Shimizu, Y. Sato, Y. Miyazaki, T. Satoh, M. Mizuno, Y. Kato, Y. Hosaka, S. Furusako: Tolllike receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice. Eur. J. Pharmacol., 569, 237-43 (2007) (Pubitemid 47198247)